News

MedPage Today1h
FDA OKs New Gene Therapy for Debilitating Skin Condition
Patients with the debilitating dermatologic condition are born with COL7A1 mutations in both gene copies, affecting the ...
Wegovy Recalled as FDA Warns Weight Loss Product 'Inappropriately Released'
A batch of the drug is under a limited voluntary recall after a shipping error exposed certain doses to improper temperatures.
BioPharma Dive6h
Abeona cell therapy approved by FDA for rare skin condition
Zevaskyn, which Abeona priced at $3.1 million, treats epidermolysis bullosa. It will compete with a gene therapy from Krystal ...
Healio7h
FDA approves Zevaskyn for treatment of recessive dystrophic epidermolysis bullosa
The FDA has approved Zevaskyn for the treatment of recessive dystrophic epidermolysis bullosa, the company announced in a ...
US FDA approves first cell-based gene therapy for rare genetic skin disorder
The U.S. Food and Drug Administration approved Abeona Therapeutics' gene therapy for a rare skin disorder on Tuesday.
The Healthy @Reader's Digest on MSN10h
Recall Affecting Diabetic Patients in 29 States Receives FDA’s Highest Risk Warning
A type of device used by more than 500,000 Americans is under scrutiny for a possible life-threatening glitch.
The Healthy @Reader's Digest on MSN14h
3 Popular Pain Relievers Have Been Recalled Nationwide
They're a group of over-the-counter meds that are arguably the most trusted to soothe aches and fever—and two major stores ...